Conversation

Notices

1. Ars Technica (arstechnica@mastodon.social)'s status on Tuesday, 18-Jun-2024 04:20:15 JST Ars Technica

   Drugmaker CEO to testify on “outrageously” priced weight-loss drugs

   Bernie Sanders cancels subpoena vote.

   https://arstechnica.com/science/2024/06/drugmaker-ceo-to-testify-on-outrageously-priced-weight-loss-drugs/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

   • freediverx (freediverx@mastodon.social)'s status on Tuesday, 18-Jun-2024 05:07:09 JST freediverx

     in reply to

     @arstechnica
     We could have had Bernie…

   • Alien software, human hardware (mavu@mastodon.social)'s status on Tuesday, 18-Jun-2024 17:49:45 JST Alien software, human hardware

     in reply to

     @arstechnica "The Committee looks forward to Mr. Jørgensen explaining why Americans are paying up to 10 or 15 times more for these medications than people in other countries"

     Why shouldn't they?
     I mean, telling a corporation what it can and can't do, that would be socialism. Right?
     /s